Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.

Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wüstenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2006 Aug;187(2):222-8. Epub 2006 May 24.

PMID:
16721614
2.

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2008 Mar;196(4):673-84. Epub 2007 Dec 21.

PMID:
18097655
3.

Dysfunction of ventral striatal reward prediction in schizophrenia.

Juckel G, Schlagenhauf F, Koslowski M, Wüstenberg T, Villringer A, Knutson B, Wrase J, Heinz A.

Neuroimage. 2006 Jan 15;29(2):409-16. Epub 2005 Sep 1.

PMID:
16139525
4.

Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia.

Juckel G, Friedel E, Koslowski M, Witthaus H, Ozgürdal S, Gudlowski Y, Knutson B, Wrase J, Brüne M, Heinz A, Schlagenhauf F.

Neuropsychobiology. 2012;66(1):50-6. doi: 10.1159/000337130. Epub 2012 Jul 13.

PMID:
22797277
5.

Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Walter H, Kammerer H, Frasch K, Spitzer M, Abler B.

Psychopharmacology (Berl). 2009 Sep;206(1):121-32. doi: 10.1007/s00213-009-1586-4. Epub 2009 Jun 12.

PMID:
19521678
6.

Neural correlates of reward processing in schizophrenia--relationship to apathy and depression.

Simon JJ, Biller A, Walther S, Roesch-Ely D, Stippich C, Weisbrod M, Kaiser S.

Schizophr Res. 2010 May;118(1-3):154-61. doi: 10.1016/j.schres.2009.11.007. Epub 2009 Dec 16.

PMID:
20005675
7.

Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients.

Esslinger C, Englisch S, Inta D, Rausch F, Schirmbeck F, Mier D, Kirsch P, Meyer-Lindenberg A, Zink M.

Schizophr Res. 2012 Sep;140(1-3):114-21. doi: 10.1016/j.schres.2012.06.025. Epub 2012 Jul 10.

PMID:
22784688
8.

Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.

Meisenzahl EM, Scheuerecker J, Zipse M, Ufer S, Wiesmann M, Frodl T, Koutsouleris N, Zetzsche T, Schmitt G, Riedel M, Spellmann I, Dehning S, Linn J, Brückmann H, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2006 Dec;256(8):522-31. Epub 2006 Dec 6.

PMID:
17151834
9.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
10.

Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia.

Dowd EC, Barch DM.

PLoS One. 2012;7(5):e35622. doi: 10.1371/journal.pone.0035622. Epub 2012 May 4.

11.

Alterations of the brain reward system in antipsychotic naïve schizophrenia patients.

Nielsen MØ, Rostrup E, Wulff S, Bak N, Lublin H, Kapur S, Glenthøj B.

Biol Psychiatry. 2012 May 15;71(10):898-905. doi: 10.1016/j.biopsych.2012.02.007. Epub 2012 Mar 13.

PMID:
22418013
12.

Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia.

Grimm O, Heinz A, Walter H, Kirsch P, Erk S, Haddad L, Plichta MM, Romanczuk-Seiferth N, Pöhland L, Mohnke S, Mühleisen TW, Mattheisen M, Witt SH, Schäfer A, Cichon S, Nöthen M, Rietschel M, Tost H, Meyer-Lindenberg A.

JAMA Psychiatry. 2014 May;71(5):531-9. doi: 10.1001/jamapsychiatry.2014.9.

PMID:
24622944
13.

Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.

Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, Lapointe JS, Honer WG.

Am J Psychiatry. 2004 Oct;161(10):1829-36.

PMID:
15465980
14.

Novel pharmacological approaches to the treatment of schizophrenia.

Fink-Jensen A.

Dan Med Bull. 2000 Jun;47(3):151-67. Review.

PMID:
10913983
15.

The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.

Kirsch P, Ronshausen S, Mier D, Gallhofer B.

Pharmacopsychiatry. 2007 Sep;40(5):196-8.

PMID:
17874350
16.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
17.

Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics.

Beck A, Schlagenhauf F, Wüstenberg T, Hein J, Kienast T, Kahnt T, Schmack K, Hägele C, Knutson B, Heinz A, Wrase J.

Biol Psychiatry. 2009 Oct 15;66(8):734-42. doi: 10.1016/j.biopsych.2009.04.035. Epub 2009 Jun 27.

PMID:
19560123
18.
19.
20.

Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients.

de Leeuw M, Kahn RS, Vink M.

Schizophr Bull. 2015 Jan;41(1):94-103. doi: 10.1093/schbul/sbu153. Epub 2014 Nov 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk